Regulatory Considerations for Prescription Drug Use-Related Software
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 20, 2026
October 20, 2026
b7ecd037-ff00-41f8-a303-6ce98d331140
Related Documents
Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers
Guidance DocumentOctober 9, 2026Center for Drug Evaluation and Research
M15 General Principles for Model-Informed Drug Development
Guidance DocumentJune 2, 2026Center for Drug Evaluation and Research
Q8, Q9, and Q10 Questions and Answers (R5)
Guidance DocumentMay 29, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.